PSA’s Psychedelic State(s) of The Union: January 27th, 2026

The article argues that the future of psychedelic legalization in the U.S. is being quietly shaped by corporate interests, particularly biotech company Compass Pathways ,through “trigger laws” that would legalize only their patented synthetic psilocybin if approved by the FDA. While grassroots efforts to legalize plant-based psychedelics struggle, corporate-backed policies are advancing quickly across multiple states. The author highlights how rapid policy momentum, combined with low public understanding, risks creating a system controlled by a small political and corporate elite rather than communities and patients. Drawing parallels to early marijuana legalization, the piece stresses the urgent need for accessible journalism and public education to ensure accountability, equitable access, and policies that prioritize public health over profit.

Read the full article on Psychedelic State(s) of America